Philip Morris International Inc. (PM) — closed signal from February 27, 2026
Partial Published before the outcome was known, scored automatically when the window closed on May 28, 2026.
Predicted vs. what happened
What happened
Reached 21% of the predicted growth at its peak, without hitting the target.
The thesis — published February 27, 2026
Philip Morris is a relatively steady defensive pick for the next few months that you'd preferably buy when the price dips. Strong sales and momentum from its Zyn brand give a positive story, but the stock is more likely to move back to its previous trend than to suddenly jump in value. Main risks: currency swings and negative news about nicotine rules that could limit how high the stock can go.
Primary drivers
- Zyn's strong sales help keep the product category growing
- As a defensive company, it may hold up when markets fall
- Buying on pullbacks gives clearer, smaller downside risk
- Currency moves or nicotine regulation can quickly cap gains
How it played out
PM: target was not reached
Lyra published PM at 189.77 on 2026-02-27 with an 8% expected gain. The thesis pointed to Zyn sales, defensive demand, and better entry after pullbacks. It also named currency moves and nicotine regulation as risks that could cap gains.
Inside the 2026-02-27 to 2026-05-28 window, PM peaked at 193.05 on 2026-05-19, a 1.7% gain. That stayed below the 204.95 target, so there were no days to target. The stock ended at 178.57. The thesis only partially played out on price, and missed its stated upside goal.
What happened during the window
On 2026-04-22, The Wall Street Journal reported that Philip Morris revenue rose 9.1% to $10.15 billion in the first quarter, while Zyn nicotine pouch shipments fell almost 24%. On 2026-05-15, The Guardian reported criticism of a new global Marlboro advertising campaign.
Prices are shown split- and dividend-adjusted, matching what public charts show today.
Read the next call before it closes.
This is one signal, scored after the fact. Today’s picks come with the same plain-language thesis — published before anyone knows the outcome.